Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
47,000
Employees47,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
47,000
Employees47,000

LLY Key Statistics

Market cap
732.45B
Market cap732.45B
Price-Earnings ratio
64.67
Price-Earnings ratio64.67
Dividend yield
0.72%
Dividend yield0.72%
Average volume
2.88M
Average volume2.88M
High today
$781.15
High today$781.15
Low today
$762.40
Low today$762.40
Open price
$779.68
Open price$779.68
Volume
2.58M
Volume2.58M
52 Week high
$972.53
52 Week high$972.53
52 Week low
$677.09
52 Week low$677.09

LLY News

Simply Wall St 21m
Eli Lilly and Company is a favorite amongst institutional investors who own 89%

Advertisement Key Insights Significantly high institutional ownership implies Eli Lilly's stock price is sensitive to their trading actions A total of 10 inv...

Eli Lilly and Company is a favorite amongst institutional investors who own 89%
TipRanks 1h
Positive Outlook for Eli Lilly & Co Driven by Strong Product Performance and International Growth

Mohit Bansal, an analyst from Wells Fargo, maintained the Buy rating on Eli Lilly & Co. The associated price target remains the same with $1,100.00. Don’t Miss...

TipRanks 16h
Eli Lilly Lowers Cost of Weight-Loss Drug as Insurance Coverage Remains Elusive

Eli Lilly (LLY) continues to lower prices for its popular weight-loss drug Zepbound. Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premium at...

Analyst ratings

83%

of 30 ratings
Buy
83.3%
Hold
10%
Sell
6.7%

More LLY News

TipRanks 4d
Eli Lilly and Regeneron: Exploring New Frontiers in Obesity Treatment

Eli Lilly And Company ((LLY)), Regeneron Pharmaceuticals ((REGN)) announced an update on their ongoing clinical study. Don’t Miss TipRanks’ Half-Year Sale Tak...

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.